Datavault AI and Wellgistics Plan $4 Billion DelivMeds AI Healthcare Platform

Datavault AI and Wellgistics Health signed a binding term sheet to form DelivMeds AI, a proposed healthcare platform that combines pharmacy infrastructure, AI-driven patient engagement, blockchain-enabled prescription management, biometric verification, and drone delivery technology.

The companies said the combined assets tied to the deal carry an expected value of about $4 billion, subject to an independent fairness opinion. The structure includes three connected transactions: expansion of Datavault AI’s PharmacyChain™ license, acquisition of QOLPOM biometric and drone logistics intellectual property, and acquisition of a controlling stake in Tollo Health.

The proposed platform would connect DelivMeds AI to Wellgistics Health’s pharmacy network of more than 6,500 pharmacies and 200 manufacturers. Wellgistics said its EinsteinRx™ AI platform would handle eligibility verification, onboarding, prior authorization, adherence support, and cash-pay fulfillment workflows.

The announcement expands a relationship between the two companies that began around PharmacyChain™, a blockchain-enabled prescription tracking and smart contract infrastructure platform introduced in 2025.